<DOC>
	<DOCNO>NCT00123487</DOCNO>
	<brief_summary>This phase III study BMS-354825 subject chronic myelogenous leukemia accelerate phase , myeloid lymphoid blast phase Philadelphia chromosome positive ( Ph+ ) acute lymphoblastic leukemia resistant intolerant imatinib mesylate ( Gleevec ) .</brief_summary>
	<brief_title>Advanced Chronic Myelogenous Leukemia ( CML ) - Follow On : Study BMS-354825 Subjects With CML</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Leukemia , Myeloid , Accelerated Phase</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . Patients PhiladelphiaPositive ( Ph+ ) ( BCR/ABL+ ) accelerate phase chronic myeloid leukemia , Ph+ ( BCR/ABL+ ) blast phase chronic myeloid leukemia , Ph+ ( BCR/ABL+ ) acute lymphoblastic leukemia whose disease primary acquire hematologic resistance imatinib mesylate intolerant imatinib mesylate Men woman , 18 year age old Adequate hepatic function Adequate renal function Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study period least 1 month least 3 month study manner risk pregnancy minimize Eastern Cooperative Oncology Group ( ECOG ) performance status score 0 2 Women pregnant breastfeed A serious uncontrolled medical disorder active infection would impair ability subject receive protocol therapy Uncontrolled significant cardiovascular disease Medications increase bleed risk Medications change heart rhythm Dementia alter mental status would prohibit understanding rendering informed consent History significant bleeding disorder unrelated CML Concurrent incurable malignancy CML Evidence organ dysfunction digestive dysfunction would prevent administration study therapy Prior therapy BMS35425 Prisoners subject compulsorily detain ( involuntarily incarcerate ) treatment either psychiatric physical ( e.g. , infectious disease ) illness must enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Accelerated Phase Chronic Myeloid Leukemia</keyword>
	<keyword>Lymphoid Blast Phase Chronic Myeloid Leukemia</keyword>
	<keyword>Myeloid Blast Phase Chronic Myeloid Leukemia</keyword>
	<keyword>Philadelphia Positive Acute Lymphoblastic Leukemia</keyword>
</DOC>